Skip to main content
. 2024 Jul 25;13(7):1463–1480. doi: 10.21037/tlcr-24-215

Figure 6.

Figure 6

Comparison of clinical outcomes between groups stratified by presence of T790M mutation. (A) Analysis of PFS among patients with EGFR mutations, stratified by the presence or absence of the T790M mutation. (B) Comparison of post-resection OS between patients with and without the T790M mutation. Although not statistically significant (P=0.054), a trend favored the T790M-positive group. PFS, progression-free survival; EGFR, epidermal growth factor receptor; OS, overall survival.